BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12208746)

  • 1. MDR1 gene polymorphisms affect therapy outcome in acute myeloid leukemia patients.
    Illmer T; Schuler US; Thiede C; Schwarz UI; Kim RB; Gotthard S; Freund D; Schäkel U; Ehninger G; Schaich M
    Cancer Res; 2002 Sep; 62(17):4955-62. PubMed ID: 12208746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
    van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
    Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A variant 2677A allele of the MDR1 gene affects fexofenadine disposition.
    Yi SY; Hong KS; Lim HS; Chung JY; Oh DS; Kim JR; Jung HR; Cho JY; Yu KS; Jang IJ; Shin SG
    Clin Pharmacol Ther; 2004 Nov; 76(5):418-27. PubMed ID: 15536457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype and allele frequencies of MDR1 gene C1236T polymorphism in a Turkish population.
    Gümüş-Akay G; Rüstemoğlu A; Karadağ A; Sunguroğlu A
    Genet Mol Res; 2008 Oct; 7(4):1193-9. PubMed ID: 19048498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
    Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
    Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.
    Sills GJ; Mohanraj R; Butler E; McCrindle S; Collier L; Wilson EA; Brodie MJ
    Epilepsia; 2005 May; 46(5):643-7. PubMed ID: 15857428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinolol.
    Siegmund W; Ludwig K; Giessmann T; Dazert P; Schroeder E; Sperker B; Warzok R; Kroemer HK; Cascorbi I
    Clin Pharmacol Ther; 2002 Nov; 72(5):572-83. PubMed ID: 12426521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of single-nucleotide polymorphisms in the multidrug resistance-1 gene on the cellular export of nelfinavir and its clinical implication for highly active antiretroviral therapy.
    Zhu D; Taguchi-Nakamura H; Goto M; Odawara T; Nakamura T; Yamada H; Kotaki H; Sugiura W; Iwamoto A; Kitamura Y
    Antivir Ther; 2004 Dec; 9(6):929-35. PubMed ID: 15651752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the C3435T and G2677T(A) polymorphisms in the ABCB1 gene and P-glycoprotein expression in human liver.
    Owen A; Goldring C; Morgan P; Chadwick D; Park BK; Pirmohamed M
    Br J Clin Pharmacol; 2005 Mar; 59(3):365-70. PubMed ID: 15752383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.
    Hur EH; Lee JH; Lee MJ; Choi SJ; Lee JH; Kang MJ; Seol M; Jang YE; Lee HJ; Kang IS; Shim SK; Ryu SG; Kang YA; Lee YS; Park CJ; Chi HS; Lee KH
    Leuk Res; 2008 Oct; 32(10):1601-4. PubMed ID: 18272218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia.
    Galimberti S; Rossi A; Palumbo GA; Morabito F; Guerrini F; Vincelli I; Fazzi R; Santini V; Petrini M
    Anticancer Res; 2003; 23(4):3419-26. PubMed ID: 12926083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDR1 gene polymorphisms and risk of gingival hyperplasia induced by calcium antagonists.
    Meisel P; Giebel J; Kunert-Keil C; Dazert P; Kroemer HK; Kocher T
    Clin Pharmacol Ther; 2006 Jan; 79(1):62-71. PubMed ID: 16413242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cyclosporine concentration and genetic polymorphisms of CYP3A5 and MDR1 during the early stage after renal transplantation.
    Azarpira N; Aghdaie MH; Behzad-Behbahanie A; Geramizadeh B; Behzadi S; Malekhoseinie SA; Raisjalal GH; Rahsaz M; Pourgholami A; Sagheb F
    Exp Clin Transplant; 2006 Jun; 4(1):416-9. PubMed ID: 16827636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation.
    Anglicheau D; Thervet E; Etienne I; Hurault De Ligny B; Le Meur Y; Touchard G; Büchler M; Laurent-Puig P; Tregouet D; Beaune P; Daly A; Legendre C; Marquet P
    Clin Pharmacol Ther; 2004 May; 75(5):422-33. PubMed ID: 15116055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic variation at the MDR1 promoter and P-glycoprotein expression and activity in AML patients.
    Lourenço JJ; Maia RC; Scheiner MA; Vasconcelos FC; Moreira MA
    Leuk Res; 2008 Jun; 32(6):976-9. PubMed ID: 18001833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism in the P-glycoprotein drug transporter MDR1 gene: a possible link between environmental and genetic factors in Parkinson's disease.
    Droździk M; Białecka M; Myśliwiec K; Honczarenko K; Stankiewicz J; Sych Z
    Pharmacogenetics; 2003 May; 13(5):259-63. PubMed ID: 12724617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene.
    Johne A; Köpke K; Gerloff T; Mai I; Rietbrock S; Meisel C; Hoffmeyer S; Kerb R; Fromm MF; Brinkmann U; Eichelbaum M; Brockmöller J; Cascorbi I; Roots I
    Clin Pharmacol Ther; 2002 Nov; 72(5):584-94. PubMed ID: 12426522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells.
    Jamroziak K; Balcerczak E; Cebula B; Janus A; Mirowski M; Robak T
    Ther Drug Monit; 2006 Oct; 28(5):707-11. PubMed ID: 17038891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A new, rapid and robust genotyping method for CYP2C9 and MDR1].
    Verstuyft C; Morin S; Yang J; Loriot MA; Barbu V; Kerb R; Brinkmann U; Beaune P; Jaillon P; Becquemont L
    Ann Biol Clin (Paris); 2003; 61(3):305-9. PubMed ID: 12805007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.